2-Methyl-2-propanyl 6-oxo-2-azaspiro[3.4]octane-2-carboxylate(CAS: 1363382-39-1)

This compound should comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for classification and labelling. In the European Union, it is subject to the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulations. Additionally, the US FDA and EPA have specific guidelines for the handling and use of this compound in pharmaceutical and industrial applications.

There are several alternatives that can be used as reagents in synthesis, such as N-methylmorpholine N-oxide (NMO) or other azaspiro compounds. These alternatives may offer different reactivity profiles and can be selected based on the specific requirements of the synthetic route.

The market for this compound is growing due to its applications in pharmaceuticals and as a building block in organic synthesis. Research trends indicate increasing interest in its use in developing novel drugs and in the exploration of its potential in biocatalysis and organocatalysis.

Waste containing this compound should be collected in appropriate containers and disposed of according to local regulations. Safe incineration or professional waste disposal services should be used, ensuring that all environmental protection measures are followed to prevent contamination of soil and water resources.